Literature DB >> 409170

Hepatic cavernous hemangiomas and hemangioendotheliomas in infancy.

P Stanley, G F Gates, R T Eto, S W Miller.   

Abstract

Six infants with either cavernous hemangiomas or hemangioendotheliomas of the liver are described. Typical clinical features include cardiac failure, hepatomegaly, and cutaneous hamangiomas. Prompt recognition will direct management to prevent lethal complications of cardiac failure, hyperconsumptive coagulopathy, and hepatic rupture. Dynamic and static hepatic scintigraphy will demonstrate the vascularity and size of the liver mass and provide distinction from other tumors, although in certain circumstances angiography is required.

Entities:  

Mesh:

Year:  1977        PMID: 409170     DOI: 10.2214/ajr.129.2.317

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Infantile hemangioendothelioma: angiographic features and factors determining efficacy of hepatic artery embolization.

Authors:  D R Burke; A Verstandig; O Edwards; S G Meranze; G K McLean; E J Stein
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

2.  Hepatic artery embolisation; successful treatment of multinodular haemangiomatosis of the liver.

Authors:  P P Vomberg; H A Büller; J W Marsman; J Lam; D J van Zaane; H S Heymans
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

3.  Infantile hepatic hemangioendothelioma with subsequent malignant degeneration.

Authors:  S G Kirchner; R M Heller; A G Kasselberg; H L Greene
Journal:  Pediatr Radiol       Date:  1981

4.  Infantile hepatic hemangioendothelioma treated by radiotherapy.

Authors:  F Corbella; M Arico; A F Podesta; A Villa; G Beluffi; E Bianchi
Journal:  Pediatr Radiol       Date:  1983

5.  Neonatal giant hepatic hemangioma: A case report.

Authors:  Zhenwei Zhu; Peng Cai; Jie Zhu; Jianlei Chen; Bin Wu; Zhicheng Gu; Shungen Huang; Jian Wang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.